Filing Details
- Accession Number:
- 0001127602-19-002480
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-22 17:01:53
- Reporting Period:
- 2016-07-01
- Accepted Time:
- 2019-01-22 17:01:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1237334 | Christopher Causey | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-07-01 | 500 | $51.77 | 1,605 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-07-01 | 500 | $108.89 | 1,105 | No | 4 | D | Direct | |
Common Stock | Disposition | 2017-08-03 | 580 | $127.48 | 3,295 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-01-18 | 750 | $63.90 | 1,725 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-01-18 | 750 | $115.75 | 975 | No | 4 | D | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | D | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Share Tracking Award | Disposition | 2016-07-01 | 500 | $0.00 | 500 | $51.77 |
Common Stock | Share Tracking Award | Disposition | 2019-01-18 | 750 | $0.00 | 750 | $63.90 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
9,500 | 2011-06-28 | 2020-06-28 | No | 4 | M | Direct |
14,250 | 2014-06-26 | 2023-06-26 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 0 | Indirect | By Ugma Account |
Footnotes
- This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- This transaction was inadvertently omitted from the reporting person's filings due to an administrative error.
- This sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.